Kestra Medical Technologies Stock Analysis
| KMTS Stock | 26.80 1.33 5.22% |
At this time, Kestra Medical's Net Debt To EBITDA is comparatively stable compared to the past year. Total Debt To Capitalization is likely to gain to 0.21 in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 33.4 M in 2026. Kestra Medical's financial risk is the risk to Kestra Medical stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.13 | Current Value 0.13 | Quarterly Volatility 0.38274777 |
Kestra Medical Technologies is fairly valued with Real Value of 25.11 and Target Price of 29.0. The main objective of Kestra Medical stock analysis is to determine its intrinsic value, which is an estimate of what Kestra Medical Technologies is worth, separate from its market price. There are two main types of Kestra Medical's stock analysis: fundamental analysis and technical analysis.
The Kestra Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kestra Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Kestra Stock trading window is adjusted to America/New York timezone.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kestra Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. Kestra Stock Analysis Notes
About 86.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.96. Kestra Medical Techn had not issued any dividends in recent years. To find out more about Kestra Medical Technologies contact the company at 425 279 8002 or learn more at https://kestramedical.com.Kestra Medical Quarterly Total Revenue |
|
Kestra Medical Techn Investment Alerts
| Kestra Medical Techn generated a negative expected return over the last 90 days | |
| Kestra Medical Techn has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 59.81 M. Net Loss for the year was (113.81 M) with profit before overhead, payroll, taxes, and interest of 34.46 M. | |
| Kestra Medical generates negative cash flow from operations | |
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Kestra Medical Technologies Stock Analysis Exploring A 16 percent Potential Upside - DirectorsTalk Interviews |
Kestra Largest EPS Surprises
Earnings surprises can significantly impact Kestra Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-12-11 | 2025-10-31 | -0.57 | -0.64 | -0.07 | 12 | ||
2025-09-12 | 2025-07-31 | -0.776 | -0.5 | 0.276 | 35 | ||
2025-07-15 | 2025-04-30 | -0.53 | -1.0595 | -0.5295 | 99 |
Kestra Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.49 B.Kestra Profitablity
The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.41) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.41.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.36) | |
| Return On Capital Employed | (0.37) | (0.39) | |
| Return On Assets | (0.35) | (0.36) | |
| Return On Equity | (0.50) | (0.52) |
Management Efficiency
Kestra Medical Techn has return on total asset (ROA) of (0.4395) % which means that it has lost $0.4395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.264) %, meaning that it created substantial loss on money invested by shareholders. Kestra Medical's management efficiency ratios could be used to measure how well Kestra Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.36 in 2026. Return On Capital Employed is likely to drop to -0.39 in 2026. At this time, Kestra Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 48.8 M in 2026, whereas Return On Tangible Assets are likely to drop (0.36) in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.73 | 3.92 | |
| Tangible Book Value Per Share | 3.73 | 3.92 | |
| Enterprise Value Over EBITDA | (9.17) | (9.63) | |
| Price Book Value Ratio | 6.67 | 6.34 | |
| Enterprise Value Multiple | (9.17) | (9.63) | |
| Price Fair Value | 6.67 | 6.34 | |
| Enterprise Value | 1.1 B | 1.2 B |
Understanding the operational decisions made by Kestra Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Technical Drivers
As of the 9th of February, Kestra Medical secures the Downside Deviation of 3.93, risk adjusted performance of 0.0112, and Mean Deviation of 2.47. Kestra Medical Technologies technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kestra Medical Techn information ratio and downside variance to decide if Kestra Medical Technologies is priced some-what accurately, providing market reflects its recent price of 26.8 per share. Given that Kestra Medical Techn has jensen alpha of (0.08), we recommend you to check Kestra Medical's last-minute market performance to make sure the company can sustain itself at a future point.Kestra Medical Techn Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Kestra Medical price series with the more recent values given greater weights.
Kestra Medical Techn Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kestra Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kestra Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kestra Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Brian Webster over three weeks ago Disposition of 15000 shares by Brian Webster of Kestra Medical at 22.8016 subject to Rule 16b-3 | ||
Brian Webster over a month ago Disposition of 15000 shares by Brian Webster of Kestra Medical at 26.5898 subject to Rule 16b-3 | ||
Cohen Raymond W over six months ago Acquisition by Cohen Raymond W of 12994 shares of Kestra Medical subject to Rule 16b-3 | ||
Hanley Conor over six months ago Insider Trading |
Kestra Medical Outstanding Bonds
Kestra Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kestra Medical Techn uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kestra bonds can be classified according to their maturity, which is the date when Kestra Medical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Kestra Medical Predictive Daily Indicators
Kestra Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kestra Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 12007.3 | |||
| Daily Balance Of Power | 0.6333 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 25.75 | |||
| Day Typical Price | 26.1 | |||
| Price Action Indicator | 1.72 | |||
| Period Momentum Indicator | 1.33 |
Kestra Medical Corporate Filings
F4 | 20th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 31st of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 11th of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 4th of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 3rd of December 2025 Other Reports | ViewVerify | |
| 2nd of December 2025 Other Reports | ViewVerify | |
8K | 1st of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 10th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Kestra Medical Forecast Models
Kestra Medical's time-series forecasting models are one of many Kestra Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kestra Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Kestra Medical Bond Ratings
Kestra Medical Technologies financial ratings play a critical role in determining how much Kestra Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Kestra Medical's borrowing costs.| Piotroski F Score | 6 | Healthy | View |
| Beneish M Score | (3.29) | Unlikely Manipulator | View |
Kestra Medical Total Assets Over Time
Kestra Medical Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Kestra Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Kestra Medical Debt Ratio | 13.0 |
Kestra Medical Corporate Bonds Issued
Kestra Short Long Term Debt Total
Short Long Term Debt Total |
|
About Kestra Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Kestra Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kestra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kestra Medical. By using and applying Kestra Stock analysis, traders can create a robust methodology for identifying Kestra entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.71) | (1.80) | |
| Operating Profit Margin | (1.60) | (1.68) | |
| Net Loss | (1.71) | (1.80) | |
| Gross Profit Margin | 0.36 | 0.38 |
Current Kestra Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kestra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kestra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 29.0 | Strong Buy | 6 | Odds |
Most Kestra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kestra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kestra Medical Techn, talking to its executives and customers, or listening to Kestra conference calls.
Kestra Stock Analysis Indicators
Kestra Medical Technologies stock analysis indicators help investors evaluate how Kestra Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Kestra Medical shares will generate the highest return on investment. By understating and applying Kestra Medical stock analysis, traders can identify Kestra Medical position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 8.6 M | |
| Long Term Debt | 41.1 M | |
| Common Stock Shares Outstanding | 49.5 M | |
| Total Stockholder Equity | 205.4 M | |
| Total Cashflows From Investing Activities | -23.3 M | |
| Tax Provision | 135 K | |
| Property Plant And Equipment Net | 36.9 M | |
| Cash And Short Term Investments | 237.6 M | |
| Cash | 237.6 M | |
| Accounts Payable | 24 M | |
| Net Debt | -193.3 M | |
| 50 Day M A | 25.3228 | |
| Total Current Liabilities | 38 M | |
| Other Operating Expenses | 166.2 M | |
| Non Current Assets Total | 40.4 M | |
| Non Currrent Assets Other | 3.5 M | |
| Stock Based Compensation | 24.3 M |
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.